Clinical Trial Update: A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating PT0511 in adults with KRAS-mutated or amplified advanced solid tumors, including colorectal cancer, pancreatic cancer, and non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• PT0511

Snippet

Sponsor: PAQ Therapeutics, Inc. | Conditions: Colorectal Cancer, Pancreatic Cancer | Phase 1 | Status: RECRUITING